ANVS Annovis Bio, Inc. Stock Quote

ANVS [NYSE]

Index	-	P/E	-	EPS (ttm)	-2.15	Insider Own	29.50%	Shs Outstand	8.16M	Perf Week	-4.99%
Market Cap	76.97M	Forward P/E	-	EPS next Y	-2.56	Insider Trans	0.00%	Shs Float	5.64M	Perf Month	-16.14%
Income	-17.20M	PEG	-	EPS next Q	-0.58	Inst Own	15.60%	Short Float	3.19%	Perf Quarter	-37.66%
Sales	-	P/S	-	EPS this Y	-119.40%	Inst Trans	-14.46%	Short Ratio	4.63	Perf Half Y	-64.23%
Book/sh	5.15	P/B	1.74	EPS next Y	7.60%	ROA	-36.90%	Target Price	31.50	Perf Year	-81.65%
Cash/sh	4.96	P/C	1.80	EPS next 5Y	-	ROE	-37.80%	52W Range	8.39 - 132.00	Perf YTD	-49.15%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-93.23%	Beta	-
Dividend %	-	Quick Ratio	34.50	Sales past 5Y	-	Gross Margin	-	52W Low	6.62%	ATR	0.87
Employees	3	Current Ratio	34.50	Sales Q/Q	-	Oper. Margin	-	RSI (14)	38.37	Volatility	7.99% 9.54%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-56.30%	Profit Margin	-	Rel Volume	0.20	Prev Close	8.61
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	38.80K	Price	8.94
Recom	1.50	SMA20	-8.44%	SMA50	-24.17%	SMA200	-58.22%	Volume	7,667	Change	3.83%

Jul-07-21

Reiterated

Maxim Group

Buy

$45 → $150

May-05-22 08:55AM	We're Not Very Worried About Annovis Bio's (NYSE:ANVS) Cash Burn Rate Simply Wall St.
May-04-22 08:30AM	Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update Newsfile +14.06%
Apr-28-22 04:30PM	Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging Newsfile
Apr-26-22 07:15AM	Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors PR Newswire -9.58%
Apr-11-22 08:30AM	Annovis Bio to Participate in World Parkinson's Day to Raise Awareness on the Debilitating Disease Newsfile
Mar-23-22 08:30AM	Annovis Bio to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest Newsfile
Mar-21-22 01:16PM	Do Institutions Own Annovis Bio, Inc. (NYSE:ANVS) Shares? Simply Wall St.
Mar-18-22 08:30AM	Annovis Bio Presents at International Conference on Alzheimer's & Parkinson (AD/PD 2022) Newsfile
Mar-08-22 08:30AM	Annovis Bio Announces Presentation at International Conference on Alzheimer's & Parkinson's Diseases 2022 Newsfile +5.57%
Mar-03-22 08:30AM	Annovis Bio to Present at the Cowen 42nd Annual Health Care Conference Newsfile -6.57%
Jan-28-22 02:01PM	Lab Notes: AmerisourceBergen teams with UK tech firm; Chimeron Bio relocates to Center City American City Business Journals
Jan-25-22 12:14PM	FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease Benzinga
09:00AM	Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease Newsfile
Jan-19-22 04:42AM	As Annovis Bio, Inc.'s market cap (NYSE:ANVS) drops to US$117m, insiders might be questioning their decision to buy earlier this year Simply Wall St.
Jan-10-22 08:30AM	Annovis Bio Enhances Leadership Team with Two Senior Appointments Newsfile
Jan-07-22 12:29PM	Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M American City Business Journals
Jan-05-22 08:30AM	Annovis Bio Announces Official Unique Name Buntanetap for Lead Candidate ANVS401 Newsfile -9.07%
Jan-03-22 08:30AM	Annovis Bio to Participate in the Biotech Showcase and H.C. Wainwright Bioconnect Virtual Conferences Newsfile +12.51%
Dec-20-21 08:30AM	Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders Newsfile
Dec-14-21 08:29AM	Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics Newsfile
Nov-20-21 06:23AM	We're Hopeful That Annovis Bio (NYSE:ANVS) Will Use Its Cash Wisely Simply Wall St.
Nov-15-21 09:00AM	Annovis Bio Announces Transfer of Listing to the New York Stock Exchange Newsfile -7.06%
Nov-12-21 10:26AM	Annovis Bio Presented At The 14th Clinical Trials on Alzheimer's Disease Conference Newsfile -7.86%
Nov-09-21 08:30AM	Annovis Bio Presents Poster on Mechanism of Action at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference Newsfile -14.81%
Nov-03-21 10:43AM	SHAREHOLDER ALERT: Robbins LLP Investigates Annovis Bio, Inc. (ANVS) for Misleading Shareholders Business Wire
Nov-02-21 08:30AM	Annovis Bio to Present at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference Newsfile +11.13%
Oct-18-21 08:10AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
07:00AM	Annovis Bio Stock Tumbled, and CEO Maria L. Maccecchini Bought Shares Barrons.com
Oct-15-21 09:00PM	ANNOVIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Annovis Bio, Inc. and Encourages Investors to Contact the Firm Business Wire -9.15%
08:56PM	SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Annovis Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - ANVS PR Newswire
04:21PM	MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
01:42PM	Insiders Are Snapping Up These 2 Beaten-Down Stocks TipRanks
08:15AM	DEADLINE MONDAY NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-14-21 07:10PM	FINAL NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Annovis Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ANVS GlobeNewswire +12.04%
04:20PM	DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
01:11PM	Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against Annovis Bio, Inc. (ANVS) GlobeNewswire
08:15AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:13AM	3 Stocks Insiders Are Buying Benzinga
Oct-13-21 10:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Annovis Bio, Cassava Sciences, The Honest Company, and Hyzon Motors and Encourages Investors to Contact the Firm GlobeNewswire
03:30PM	SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Annovis Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - ANVS ACCESSWIRE
12:00PM	CLASS ACTION UPDATE for ANVS, HNST and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM	ANVS Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Annovis Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 18, 2021 ACCESSWIRE
11:00AM	ANVS INVESTOR ALERT: Shareholder Class Action Lawsuit Filed ACCESSWIRE
10:45AM	LAWSUITS FILED AGAINST ANVS, EAR and HYZN - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
10:20AM	Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Annovis Bio, Inc. Investors in Securities Fraud Class Action Lawsuit PR Newswire
08:49AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - ANVS Newsfile
08:30AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-12-21 10:49PM	FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ANVS, PYPL, SESN and SLQT GlobeNewswire
09:06PM	ANVS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Annovis Bio, Inc. Newsfile
08:10PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of LIVE, ANVS and SAVA ACCESSWIRE
06:40PM	Final Deadline Approaching on October 18, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Annovis Bio, Inc. Investors of Class Action Lawsuit Deadline Newsfile
05:28PM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - (ANVS) Newsfile
04:30PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPLT, ANVS and WDH ACCESSWIRE
04:30PM	ANVS, HNST, PYPL SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
03:37PM	MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
03:10PM	MONDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Annovis Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ANVS ACCESSWIRE
03:03PM	ANVS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Annovis Bio, Inc. Limited Shareholders Newsfile
01:38PM	ANVS MONDAY DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Annovis Bio, Inc. Investors to Secure Counsel Before Important October 18 Deadline in Securities Class Action ANVS GlobeNewswire
12:45PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ANVS, VIEW and SESN ACCESSWIRE
12:15PM	DEADLINE ALERT for ANVS, VIEW, and SESN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:20AM	LAWSUITS FILED AGAINST ANVS, VIEW and WDH - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
08:30AM	MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:28AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - ANVS Newsfile
05:40AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SLQT, ANVS and ATIP ACCESSWIRE
Oct-11-21 11:55PM	ANNOVIS BIO Investor Alert: Class Action Lawsuit Filed Newsfile
10:47PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ANVS, BMY, HNST, PYPL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
06:17PM	ANVS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Annovis Bio, Inc. Newsfile
05:15PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of YALA, LIVE and ANVS ACCESSWIRE
04:25PM	ANVS INVESTOR OCTOBER 18, 2021 FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Annovis Bio, Inc. ACCESSWIRE
04:15PM	CLASS ACTION UPDATE for ANVS, SAVA and WDH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:25PM	INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of ANVS, HNST, PYPL Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
11:13AM	ANVS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Annovis Bio, Inc. Limited Shareholders Newsfile
11:00AM	ANVS Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Annovis Bio, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 18, 2021 Business Wire
09:34AM	DEADLINE NEXT WEEK: Annovis Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ANVS Newsfile
09:15AM	SHAREHOLDER ALERT: PHG KPLT ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:08AM	Annovis Bio, Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit ACCESSWIRE
08:35AM	7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:26AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - ANVS Newsfile
Oct-10-21 09:00PM	ANNOVIS BIO INVESTOR ALERT: Shareholder Lawsuit Filed ACCESSWIRE
04:07PM	DEADLINE APPROACHING: Robbins Geller Rudman & Dowd LLP Announces that Annovis Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ANVS ACCESSWIRE
10:35AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANVS, VIEW and HYZN ACCESSWIRE
Oct-09-21 06:05PM	UPCOMING DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Annovis Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ANVS GlobeNewswire
04:28PM	SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Annovis Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - ANVS Newsfile
10:22AM	Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Annovis Bio, Inc. (ANVS) ACCESSWIRE
10:15AM	ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS PR Newswire
Oct-08-21 11:45PM	ANNOVIS BIO, INC. (ANVS) INVESTOR CLASS ACTION LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Annovis Bio, Inc. Newsfile
10:50PM	SHAREHOLDER ALERT: CLAIMSFILER REMINDS ANVS, PYPL, SESN, SLQT INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
07:19PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:04PM	Annovis Bio, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
04:45PM	ANVS Investor Alert: Shareholder Lawsuit Filed Newsfile
03:00PM	FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Annovis Bio, Inc. Investors with LARGE LOSSES to Secure Counsel Before Important October 18 Deadline in Securities Class Action - ANVS ACCESSWIRE
02:30PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SLQT, ANVS and WDH ACCESSWIRE
01:00PM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Annovis Bio, Inc. (ANVS) GlobeNewswire
11:55AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SLQT, ANVS and HYZN ACCESSWIRE
11:00AM	SLQT, ANVS & VIEW Class Actions and Deadlines - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
09:14AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - ANVS Newsfile
07:45AM	INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:30AM	CLASS ACTION UPDATE for SLQT, ANVS and VIEW: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Oct-07-21 10:50PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ANVS, HNST, PYPL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits ACCESSWIRE
10:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Annovis Bio, Cassava Sciences, The Honest Company, and Hyzon and Encourages Investors to Contact the Firm GlobeNewswire

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maccecchini Maria-Luisa	President and CEO	Jan 14	Option Exercise	0.14	32,959	4,614	987,734	Jan 18 09:08 PM
Hoffman Michael B	Director	Jan 04	Option Exercise	3.59	37,142	133,486	1,416,373	Jan 05 07:41 PM
White Mark K.	Director	Oct 12	Buy	27.40	5,000	137,000	56,177	Oct 13 04:02 PM
Bruck Claudine	Director	Oct 11	Buy	27.66	181	5,006	6,067	Oct 13 04:03 PM
Maccecchini Maria-Luisa	PRESIDENT AND CEO	Oct 11	Buy	27.61	18,000	496,980	976,775	Oct 13 04:00 PM
McCarthy Reid	Director	Aug 19	Buy	37.61	500	18,805	6,829	Aug 23 11:36 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience